A Day Up For Biocept, Inc.

Fri 28 Feb 20 at 05:30 PM
A Day Up For Biocept, Inc.

Biocept, Inc. (BIOC:NASDAQ) shot up at $0.78, a gain of 168.9%. On Thu 27 Feb 20, BIOC:NASDAQ touched a New 2-Week Low of $0.29. The stock got featured on our News Catalysts scanner on Mon 10 Feb 20 at 09:19 AM in the 'AGREEMENT' category. From Thu 06 Feb 20, the stock recorded 28.57% Up Days and 20.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Biocept, Inc. (BIOC:NASDAQ)

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.